Johan Holst
Overview
Explore the profile of Johan Holst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
408
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Heinrich M, Boisen M, Nelson D, Bush D, Cross R, Koval A, et al.
Sci Rep
. 2020 Sep;
10(1):16030.
PMID: 32994446
Lassa virus (LASV) is the causative agent of Lassa fever, an often-fatal hemorrhagic disease that is endemic in West Africa. Seven genetically distinct LASV lineages have been identified. As part...
2.
Bernasconi V, Kristiansen P, Whelan M, Roman R, Bettis A, Yimer S, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
. 2020 Jan;
63(2):226.
PMID: 31915867
In the original publication of this article, the author name Richard Hatchett was incorrectly published.
3.
Bernasconi V, Kristiansen P, Whelan M, Roman R, Bettis A, Yimer S, et al.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz
. 2019 Nov;
63(1):65-73.
PMID: 31776599
Today's world is characterized by increasing population density, human mobility, urbanization, and climate and ecological change. This global dynamic has various effects, including the increased appearance of emerging infectious diseases...
4.
Koski K, Holst J
J Bioeth Inq
. 2017 Aug;
14(3):411-426.
PMID: 28815488
This project explores vaccine hesitancy through an artist-scientist collaboration. It aims to create better understanding of vaccine hesitant parents' health beliefs and how these influence their vaccine-critical decisions. The project...
5.
Holst J, Comanducci M, Bambini S, Muzzi A, Comandi S, Oksnes J, et al.
Vaccine
. 2014 Mar;
32(23):2722-31.
PMID: 24631075
Surface-expressed protein antigens such as factor H-binding protein (fHbp), Neisserial adhesin A (NadA), Neisserial heparin-binding antigen (NHBA) and Porin protein A (PorA); all express sequence variability that can affect their...
6.
Holst J, Oster P, Arnold R, Tatley M, Naess L, Aaberge I, et al.
Hum Vaccin Immunother
. 2013 Jul;
9(6):1241-53.
PMID: 23857274
The utility of wild-type outer membrane vesicle (wtOMV) vaccines against serogroup B (MenB) meningococcal disease has been explored since the 1970s. Public health interventions in Cuba, Norway and New Zealand...
7.
Holst J, Nokleby H, Bettinger J
Vaccine
. 2012 May;
30 Suppl 2:B57-62.
PMID: 22607900
The development of conjugate vaccines has enabled the prevention and control of Neisseria meningitidis caused by serogroups A, C, W-135 and Y. Vaccines that provide protection against a broad number...
8.
Harrison L, Pelton S, Wilder-Smith A, Holst J, Safadi M, Vazquez J, et al.
Vaccine
. 2011 Mar;
29(18):3363-71.
PMID: 21376800
The Global Meningococcal Initiative (GMI) is composed of an international group of scientists, clinicians and public health officials with expertise in meningococcal immunology, epidemiology and prevention. The primary goal of...
9.
Romeu B, Gonzalez E, Campa C, Holst J, Perez O
Expert Rev Vaccines
. 2009 Jul;
8(8):987-92.
PMID: 19627182
A 5-day workshop on Neisseria vaccines was held in Varadero, Cuba, 17-22 May 2009, and hosted by the Latin American Association for Immunology and the Cuban Society for Immunology, which...
10.
Holst J, Martin D, Arnold R, Huergo C, Oster P, OHallahan J, et al.
Vaccine
. 2009 Jun;
27 Suppl 2:B3-12.
PMID: 19481313
Meningococcal outer membrane proteins have been used for over 20 years in more than 80 million doses; either as carrier protein in a Haemophilus influenzae type b (Hib) polysaccharide conjugate...